David McNabb, MD
Orthopaedic Surgery · Raleigh, NCNPI 1598990277
Payments from drug & device makers
Across 62 payments — averaging $309.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Total Joint Orthopedics, Inc.$17K
- Zimmer Biomet$735
- Stryker$483
- Southtech Orthopedics$318
- Smith+Nephew$155
- Johnson & Johnson$147
- plus $186 from 8 others
What the payments were for
- Consulting fees$15,75082%
- Travel & lodging$3092%
- Food & beverage$2,83515%
- Education$3182%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Total Joint Orthopedics, Inc. | 30 | $17,188 |
| Zimmer Biomet | 6 | $735 |
| Stryker | 6 | $483 |
| Southtech Orthopedics | 1 | $318 |
| Smith+Nephew | 7 | $155 |
| Johnson & Johnson(2 entities) | 2 | $147 |
| Heraeus Medical, LLC. | 2 | $50 |
| Baxter Healthcare | 1 | $34 |
| Arthrex | 2 | $30 |
| Heron Therapeutics, Inc. | 1 | $26 |
| KCI USA, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Convatec Inc. | 1 | $13 |
| SPR Therapeutics, Inc | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$402
- Persona Revision$275
- ROSA-Knee$137
- Persona$132
How this compares
$19,211 in reported general payments places this provider in the 70th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 68 | $784 |
| Amoxicillin | 310 | $555 |
| Meloxicam | 164 | $424 |
| Oxycodone Hcl | 49 | $216 |
| Clindamycin Hcl | 65 | $215 |
| Cefadroxil | 15 | $172 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $168 |
| Ondansetron OdtOndansetron | 17 | $120 |
| Prednisone | 29 | $108 |
| Tramadol Hcl | 46 | $95 |
| Famotidine | 14 | $88 |
| Methylprednisolone | 12 | $74 |
| Tizanidine Hcl | 12 | $39 |
| Diazepam | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Raleigh
- Gurvinder DeolRaleigh$2.8M
- Rhett HallowsRaleigh$388K
- John NelsonRaleigh$234K
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$6.2M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.